Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Debility, unspecified: a terminal diagnosis

B M Kinzbrunner, N J Weinreb, M P Merriman

    The American Journal of Hospice & Palliative Care
    |November 1, 1996
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A randomized trial comparing the efficacy and safety of imiglucerase (Cerezyme) infusions every 4 weeks versus every 2 weeks in the maintenance therapy of adult patients with Gaucher disease type 1.

    Molecular genetics and metabolism·2009
    Same author

    Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study.

    Clinical genetics·2008
    Same author

    The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease.

    Clinical genetics·2007
    Same author

    Hospice: 15 years and beyond in the care of the dying.

    Journal of palliative medicine·2005
    Same author

    Precedents for hospice and surrogate decision-making in Jewish law.

    Tradition (Rabbinical Council of America)·2003
    Same author

    Skeletal aspects of Gaucher disease: a review.

    The British journal of radiology·2002
    Same journal

    Relationships Between Advance Care Planning Engagement, Patients' Religious Practices, and Spirituality.

    The American journal of hospice & palliative care·2026
    Same journal

    The Efficacy of Spiritual Care Intervention on Readmissions of Hospitalized Patients Receiving Palliative Care: A Quasi-Experimental Pilot Study Proposal.

    The American journal of hospice & palliative care·2026
    Same journal

    Nurse-Led Advance Care Planning Interventions for Patients with Advanced Cancer: A Systematic Review.

    The American journal of hospice & palliative care·2026
    Same journal

    Self-Reported Cannabis Use and Symptom Burden Among Patients With Cancer Receiving Palliative Care.

    The American journal of hospice & palliative care·2026
    Same journal

    Efficacy of Oxygen Therapy for the Relief of Dyspnea in Palliative Care: A Systematic Review.

    The American journal of hospice & palliative care·2026
    Same journal

    Survival Heterogeneity in U.S. Hospice Patients: A Retrospective Cohort Study.

    The American journal of hospice & palliative care·2026
    See all related articles

    The diagnosis "debility, unspecified" is appropriate for terminally ill patients when multiple conditions exist. This study confirms its validity for hospice care, aiding in accurate diagnosis assignment.

    Area of Science:

    • Palliative Care
    • Medical Diagnostics
    • Geriatrics

    Background:

    • The diagnosis "debility, unspecified" (ICD-9 code 799.3) is often used in hospice care.
    • Its appropriateness for terminally ill patients requires clear diagnostic criteria.

    Purpose of the Study:

    • To evaluate the suitability of "debility, unspecified" as a terminal diagnosis.
    • To establish criteria for its accurate assignment in hospice settings.

    Main Methods:

    • Retrospective chart review of patients diagnosed with "debility, unspecified" in a hospice program.
    • Analysis of patient demographics, functional status, comorbidities, and survival data.

    Main Results:

    • "Debility, unspecified" was confirmed in 50 of 53 cases.

    Related Experiment Videos

  • All confirmed cases involved patients with multiple comorbid conditions and significant organ system impairments (CNS, cardiopulmonary, skin, sepsis).
  • No single major system impairment justified a more specific terminal diagnosis.

    • Conclusions:

    • "Debility, unspecified" is an appropriate terminal diagnosis for patients with multiple comorbidities and no single dominant life-limiting condition.
    • Survival data and hospice length of stay support its use.
    • A decision tree is provided to guide diagnosis assignment.